HighMark Wealth Management LLC reported 407 positions worth $98.75M for the quarter ended Jun 30, 2026, up 31.4% on the prior quarter. It opened 32 new positions, added to 100, trimmed 73 and exited 30. Its largest holding is Axogen, Inc. at 16% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| SIBN SI-BONE, Inc. | +265.2K | +165.9% | $4.33M | 7.02% |
| DUOT Duos Technologies Group, Inc. | +289.9K | – | $3.48M | 3.52% |
| NPCE NeuroPace Inc | +100.0K | +158.7% | $1.59M | 2.62% |
| NEO Neogenomics Inc | +32.7K | +5.6% | $477.09K | 9.05% |
| OKE Oneok Inc | +2,750 | – | $239.09K | 0.242% |
| SNDK Sandisk Corp | +100 | – | $227.37K | 0.23% |
| MASS 908 Devices Inc. | +20.4K | +6.4% | $177.77K | 2.99% |
| SEZL Sezzle Inc. | +1,000 | – | $171.63K | 0.174% |
| RBBN Ribbon Communications Inc. | +69.0K | – | $161.46K | 0.164% |
| BAER Bridger Aerospace Group Holdings, Inc. | +90.0K | +69.1% | $149.25K | 0.37% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| ANAB Anaptysbio, Inc | -54.3K | -57.8% | $3.67M | 2.71% |
| PIPR Piper Sandler Companies | -15.6K | -99.1% | $1.13M | 0.01% |
| ORGO Organogenesis Holdings Inc. | -291.2K | -96.1% | $707.63K | 0.029% |
| NVDA Nvidia Corp | -931 | -7.3% | $186.29K | 2.4% |
| AXGN Axogen, Inc. | -3,550 | -1.0% | $163.97K | 15.97% |
| AAPL Apple Inc. | -232 | -3.0% | $67.13K | 2.23% |
| DXCM Dexcom Inc | -960 | -33.7% | $64.66K | 0.129% |
| HCAT Health Catalyst, Inc. | -32.0K | -3.5% | $63.68K | 1.76% |
| MA Mastercard Inc | -99 | -46.9% | $50.67K | 0.058% |
| STX Seagate Technology Holdings plc | -100 | -100.0% | $39.18K | Exited |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| DUOT Duos Technologies Group, Inc. | +289.9K | $3.48M | 3.52% |
| OKE Oneok Inc | +2,750 | $239.09K | 0.242% |
| SNDK Sandisk Corp | +100 | $227.37K | 0.23% |
| SEZL Sezzle Inc. | +1,000 | $171.63K | 0.174% |
| RBBN Ribbon Communications Inc. | +69.0K | $161.46K | 0.164% |
| SPCX Space Exploration Technologies Corp | +480 | $82.01K | 0.083% |
| ARM Arm Holdings Plc | +50 | $17.73K | 0.018% |
| RXT Rackspace Technology, Inc. | +2,500 | $16.33K | 0.017% |
| JPM Jpmorgan Chase & Co | +30 | $9.82K | <0.01% |
| MET Metlife Inc | +115 | $9.73K | <0.01% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| STX Seagate Technology Holdings plc | -100 | $39.18K | 0.052% |
| GLOB Globant S.A. | -547 | $25.22K | 0.034% |
| PAYC Paycom Software, Inc. | -187 | $22.73K | 0.03% |
| APYX Apyx Medical Corp | -5,000 | $18.45K | 0.025% |
| ABVX Abivax S.A. | -150 | $16.70K | 0.022% |
| CBOE Cboe Global Markets, Inc. | -35 | $9.84K | 0.013% |
| NOV NOV Inc. | -465 | $8.75K | 0.012% |
| CDNA CareDx, Inc. | -475 | $8.25K | 0.011% |
| NEE Nextera Energy Inc | -79 | $7.34K | <0.01% |
| BJ BJ's Wholesale Club Holdings, Inc. | -63 | $6.20K | <0.01% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | AXGN Axogen, Inc. | Healthcare | 341.4K | $15.77M | 15.97% | -3,550 | -1.0% | Reduced | 0.64% |
| 2 | NEO Neogenomics Inc | Healthcare | 612.5K | $8.94M | 9.05% | +32.7K | +5.6% | Added | 0.47% |
| 3 | SIBN SI-BONE, Inc. | Healthcare | 425.0K | $6.94M | 7.02% | +265.2K | +165.9% | Added | 0.95% |
| 4 | WFC Wells Fargo & Company | Financial Services | 68.6K | $5.67M | 5.74% | +47 | +0.1% | Added | 0% |
| 5 | TWST Twist Bioscience Corp | Healthcare | 39.0K | $4.02M | 4.07% | -260 | -0.7% | Reduced | 0.06% |
| 6 | DUOT Duos Technologies Group, Inc. | Technology | 289.9K | $3.48M | 3.52% | +289.9K | – | New | 0.96% |
| 7 | MASS 908 Devices Inc. | Industrials | 339.8K | $2.96M | 2.99% | +20.4K | +6.4% | Added | 0.89% |
| 8 | ANAB Anaptysbio, Inc | Healthcare | 39.7K | $2.68M | 2.71% | -54.3K | -57.8% | Reduced | 0.14% |
| 9 | NPCE NeuroPace Inc | Healthcare | 163.0K | $2.59M | 2.62% | +100.0K | +158.7% | Added | 0.48% |
| 10 | NVDA Nvidia Corp | Technology | 11.8K | $2.37M | 2.4% | -931 | -7.3% | Reduced | 0% |
| 11 | ATRC AtriCure, Inc. | Healthcare | 83.7K | $2.34M | 2.37% | 0 | 0.0% | Unchanged | 0.16% |
| 12 | AAPL Apple Inc. | Technology | 7,608 | $2.20M | 2.23% | -232 | -3.0% | Reduced | 0% |
| 13 | EWTX Edgewise Therapeutics, Inc. | Healthcare | 53.2K | $2.16M | 2.19% | 0 | 0.0% | Unchanged | 0.05% |
| 14 | LLY ELI LILLY & Co | Healthcare | 1,734 | $2.08M | 2.11% | +6 | +0.3% | Added | 0% |
| 15 | TRV Travelers Companies, Inc. | Financial Services | 5,606 | $1.85M | 1.87% | +31 | +0.6% | Added | 0% |
Tip. Select a row to see that position’s full history at HighMark Wealth Management.
As of its Q2 2026 13F filing, HighMark Wealth Management LLC’s five largest positions were Axogen, Inc. (AXGN) at 16.0%, Neogenomics Inc (NEO) at 9.1%, SI-BONE, Inc. (SIBN) at 7.0%, Wells Fargo & Company (WFC) at 5.7%, Twist Bioscience Corp (TWST) at 4.1% of the reported portfolio.
HighMark Wealth Management LLC reported a 13F portfolio worth $98.75M across 407 positions for Q2 2026. That is up 31.4% from the previous quarter.
Its largest purchases by value were SI-BONE, Inc. ($4.33M), Duos Technologies Group, Inc. ($3.48M), NeuroPace Inc ($1.59M). It opened 32 new positions.
Its largest sales by value were Anaptysbio, Inc ($3.67M), Piper Sandler Companies ($1.13M), Organogenesis Holdings Inc. ($707.63K). It exited 30 positions entirely.
From the Form 13F-HR reports HighMark Wealth Management LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.